News, features, and commentary about cancer-related issues ...

A gene called FOXJ1 may drive resistance to taxane chemotherapy during treatment for advanced prostate cancer, according to a new study led by investigators at Weill Cornell Medicine and Beth Israel ...

In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of ...

The treatment, a type of immunotherapy which harnesses the body’s immune system to fight cancer, was found to shrink tumours ...

New prostate cancer drug showing ‘remarkable’ results during clinical trial - The new drug, known as VIR-5500, uses a ...

Learn how Huntsman Cancer Institute uses cutting‑edge diagnostics and personalized care to treat early‑stage prostate cancer. Discover why early detection makes treatment more effective and far less ...

A drug for advanced prostate cancer has shown “remarkable” results in an early-stage trial, with patients who had previously ...

In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of anticoagulants published by Wiley online in CANCER, investigators found ...

In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of ...

There are different ways to manage fatigue during prostate cancer treatment, including exercise, sleep, complementary ...

Scientists have reported results from an early-stage trial of an immunotherapy drug called VIR-5500. The drug offers new hope for men with advanced prostate cancer who have stopped responding to other ...

A drug for advanced prostate cancer has shown "remarkable" results in an early-stage trial, experts have said.